Limitations, agreements, and source contact

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · Source last updated 2021-10-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

evokes@medicine.bsd.uchicago.edu

organization

University of Chicago Medicine and Biological Sciences

phone

855-702-8222

title

Dr Everett Vokes, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice